AlJohani NI. Remission frequency versus remission quality in transplant-eligible older patients. Comment on: “Treatment of therapy-related acute myeloid leukemia and acute myeloid leukemia with myelodysplasia-related changes: a comparative analysis of higher-dose intensive 7+3 induction chemotherapy versus liposomal cytarabine and daunorubicin”. Haematologica; https://doi.org/10.3324/haematol.2026.301453 [Early view].